Brand-Backed ASBM Pushes Back On Biosimilar Reforms

 
• By David Wallace
  
Large yellow arrow opposing multiple small white arrows on chalkboard
The ASBM is pushing back against recent FDA moves on biosimilars. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics